Author:
Liao Bin-Chi,Lin Chia-Chi,Yang James Chih-Hsin
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
129 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis and anti-breast cancer evaluation of fused imidazole-imidazo[1,2-c][1,2,3]triazoles: PEG-400 mediated one-pot reaction under ultrasonic irradiation;Journal of Molecular Structure;2024-09
2. Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment;Biomedicines;2024-08-08
3. Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop software;Heliyon;2024-07
4. Synthesis of novel pyrido[3,4‐d]pyrimidine‐thiazolidione‐1,2,4‐oxadiazoles as potent EGFR targeting anticancer agents;Journal of Heterocyclic Chemistry;2024-06-16
5. Synthesis, Anti-Breast Cancer, and EGFR Activity of Novel Pyrido[2,3-d]pyrimidine-piperazine-1,2,4-oxadiazoles;Russian Journal of General Chemistry;2024-06